Arcadia Biosciences Income Statement - Quarterly (NASDAQ:RKDA)

Add to My Stocks
$1.13 $0 (0.18%) RKDA stock closing price Dec 02, 2016 (Closing)

Looking at financial statements, along with the Arcadia Biosciences stock price, it's management, its economic moat, and industry competitors forms an important part of fundamental analysis.   An income statement is one of the three key financial statements furnished by a company, the other two being the balance sheet and the cashflow statement. The income statement for RKDA which implies a QoQ revenue growth of $0.36M is specific to a period of time. Investors typically check YoY or QoQ revenue growth. Along with Arcadia Biosciences assets and Arcadia Biosciences free cash flow, profits as shown in profit and loss statement give key insights about the business. The profits have increased from $-4.55M QoQ and 2016-Q3 revenue is $1.08M. View details of revenue and profits for Arcadia Biosciences for latest & last 40 quarters.

show more
Annual
Quarterly
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec. 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2
Arcadia Biosciences Net Sales or Revenues
1.08M0.72M0.85M1.35M1.82M1.43M0.82M2.8M1.5M1.31M
Cost Of Goods Sold (COGS)0.06M0.03M0.14M0.68M0.06M0.1M0.05M0.07M1.79M0.04M
Arcadia Biosciences Gross Profit
1.01M0.68M0.7M0.69M1.76M1.32M0.75M2.74M-0.29M1.25M
Research & Development Expense2.25M2.21M2.2M1.88M3.17M2.08M1.83M2.08M3.68M2.27M
Selling General & Admin Expense2.68M2.75M3.43M2.89M2.81M2.78M2.63M2.3M1.96M3.98M
Income Before Depreciation Depletion Amortization-3.92M-4.28M-4.93M-4.08M-4.23M-3.54M-3.71M-1.64M-5.94M-4.99M
Depreciation Depletion Amortization----------
Non Operating Income0.09M0.07M0.07M0.67M0.28M0.73M-1.39M0.02M-0.81M0.22M
Interest Expense0.33M0.32M0.32M0.66M0.76M0.77M0.46M0.36M0.26M0.39M
Arcadia Biosciences Pretax Income
-4.16M-4.54M-5.18M-4.07M-4.71M-3.58M-5.57M-1.97M-7.02M-5.17M
Provision for Income Taxes0.01M0.01M0.01M-0.2M-0.09M0.09M0.22M0.04M0.04M0.09M
Minority Interest----------
Investment Gains Losses--------0.01M--0.53M
Other Income----------
Income Before Extraordinaries & Disc Operations-4.18M-4.55M-5.19M-3.86M-4.62M-3.68M-5.8M-1.99M-7.06M-5.81M
Extraordinary Items & Discontinued Operations----------
Arcadia Biosciences Net Income (Profit/Loss)
-4.18M-4.55M-5.19M-3.86M-4.62M-3.68M-5.8M-1.99M-7.06M-5.81M
Average Shares used to compute Diluted EPS44.37M44.31M44.22M44.11M43.65M23.78M2.08M2.07M2.06M2.06M
Average Shares used to compute Basic EPS44.37M44.31M44.22M44.11M43.65M23.78M2.08M2.07M2.06M2.06M
Income Before Nonrecurring Items-4.18M-4.55M-5.19M-3.63M-4.62M-3.68M-5.8M-1.99M-7.06M-5.81M
Income from Nonrecurring Items----0.23M------
Arcadia Biosciences Earnings Per Share Basic Net
-0.09-0.10-0.12-0.09-0.11-0.19-3.71-1.76-4.19-3.08
Arcadia Biosciences Earnings Per Share Diluted Net
-0.09-0.10-0.12-0.09-0.11-0.19-3.71-1.76-4.19-3.08
EPS Diluted Before Nonrecurring Items-0.09-0.10-0.12-0.08-0.11-0.19-3.71-1.76-4.19-3.08
Preferred Dividends Acc Pd----------
Dividends Common----------
Dividend Per Share Common----------
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters
Get Income statement for another ticker

The key things to look for in an income statement while doing Arcadia Biosciences stock analysis are:
  • Topline: A growing topline, as seen from the Arcadia Biosciences revenue chart, as is the case with Arcadia Biosciences indicates a growing business. One needs to compare the QoQ or YoY topline growth of RKDA stock with its peers like ANDE stock and YONG stock to see if the growth compares well with what can be expected for a company in that industry.
  • Bottom line: The word bottom line comes because it is usually the last line of the income statement and refers to the actual profits after deducting all expenses from the revenues. RKDA stock had a healthy bottom line growth.
The income statement is also called statement of revenue and expense. The financials along with Arcadia Biosciences historical stock prices provides a lot of details about the firm. .

Arcadia Biosciences Income Statement - Key Financial Ratios

PS ratio (
price sales ratio
)
12.5123
Operating margin
-363
Net profit margin
-387
Dividend yield
0%